Yüksel Ürün· @DrYukselUrun · X·· 15 小时前评分70
正文 · 原文
A long-awaited breakthrough in cancer vaccines.
One patient. One tumor. One personalized mRNA vaccine.
INTErpath-001 brings this vision closer to clinical reality. Are we ready to deliver it?
@myESMO @OncoAlert @OpenMedicineHQ #ESMO26 @ProfGLongMIA @FAndreMD @curijoey @YJanjigianMD
149 浏览 · 2 赞 · 2 转发 · 0 回复
会议摘要
LBA1按 Presidential Symposium I 对上
INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)
https://esmocongress.esmo.orgINTerpath-001
https://esmocongress.esmo.org来源：Yüksel Ürün · x.com